Mirror, Mirror 2024 is your opportunity to explore the impact of policy choices on health and well-being across 10 countries, including the U.S. Read the report here.

Prescription Drugs

Overview Resources

Rows of pills

Controlling Health Care Costs

Key Provisions of Drug Pricing Proposals

publication / Apr 26, 2021

prescription drug prices in the US

Controlling Health Care Costs

Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?

Issue Briefs / Oct 05, 2017

Pharmacist and patient discussing prescription drugs

Controlling Health Care Costs

The Case for Drug-Pricing Reform — The Cost of Inaction

blog / May 26, 2021

Featured

Pills pouring out into a mans hand

Controlling Health Care Costs

Allowing Medicare to Negotiate Drug Prices

Explainer / May 05, 2021

Medicare recipient sorting prescriptions

Controlling Health Care Costs

Inflation Rebate Penalty for Drug Companies

Explainer / Jun 17, 2021

Woman and pharmacist speaking, both wearing masks

Controlling Health Care Costs

Medicare Part D Redesign

Explainer / May 05, 2021

Doris Hölzl, pharmacist, gives FFP2 masks to a customer in a pharmacy in Berlin-Wilmersdorf as part of the free distribution of FFP2 masks to risk groups.

Controlling Health Care Costs

External Reference Pricing: The Drug-Pricing Reform America Needs?

Issue Briefs / May 27, 2021

senior woman on phone looks at pill packets on table

Controlling Health Care Costs

How Federal Drug-Pricing Proposals Could Affect Medicaid

blog / Aug 19, 2021

blue pills in machine manufactured with white gloved hand in background

Controlling Health Care Costs

Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs

blog / Aug 18, 2021

Search content about
Prescription Drugs

lower drug costs state flexibility

Controlling Health Care Costs

Lower Drug Costs: The Next Frontier for State Flexibility

Blog / Feb 20, 2018

Trump budget prescription drug proposal

Controlling Health Care Costs

Trump Budget’s Prescription Drug Proposals Would Lower Patients’ Costs and Federal Spending; Some Could Lower Drug Prices

Blog / Feb 13, 2018

Budget bill considerations by Congress

Controlling Health Care Costs

Three Key Health Issues Congress Could Consider in 2018 Budget Deal

Blog / Feb 02, 2018

Competition among drug manufacturers

Controlling Health Care Costs

Bipartisan Bill Would Increase Competition Among Drug Manufacturers and Lower Drug Prices

Blog / Jan 29, 2018

Older adults in the US are sicker and have more financial barriers to care

Advancing Health Equity

Older Americans Were Sicker and Faced More Financial Barriers to Health Care Than Counterparts in Other Countries

Journal Article / Nov 15, 2017

Q&A Header

Controlling Health Care Costs

Brand-Name Drugs and Generics: Balancing Innovation with Cost Control

Journal Article / Nov 03, 2017

medications

Controlling Health Care Costs

Payers’ Experiences with Confidential Pharmaceutical Price Discounts: A Survey of Public and Statutory Health Systems in North America, Europe, and Australasia

Journal Article / Oct 31, 2017

Improving Health Care Quality

To Combat the Opioid Epidemic, We Must Be Honest About All Its Causes

Blog / Oct 26, 2017

Controlling Health Care Costs

A Path Toward Understanding and Lowering U.S. Prescription Drug Spending

Blog / Oct 17, 2017

market exclusivity for prescription drugs in the US

Controlling Health Care Costs

Why Are U.S. Prescription Drug Prices So High?

Other Publication / Oct 17, 2017

prescription drug prices in the US

Controlling Health Care Costs

Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?

Issue Briefs / Oct 05, 2017

high drug spending

Controlling Health Care Costs

Outcomes-Based Pharmaceutical Contracts: An Answer to High U.S. Drug Spending?

Issue Briefs / Sep 27, 2017

1 … 5 6 7 8 9 10 11 12 13 14